2011
DOI: 10.1016/j.ijsu.2011.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Emerging indications for percutaneous cholecystostomy for the management of acute cholecystitis – A retrospective review

Abstract: PC is a low risk management option for high risk patients with acute cholecystitis. It can be used as a temporizing measure while awaiting resolution of sepsis and optimization of co-morbidities, or as a definitive therapeutic option for acalculous cholecystitis. We also conclude that it has a good potential to be used as a definitive therapy for high risk (ASAIII & IV) patients with acute calculous cholecystitis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
26
0
2

Year Published

2013
2013
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(33 citation statements)
references
References 11 publications
3
26
0
2
Order By: Relevance
“…Excluding patients with limited life expectancy caused by advanced malignancy or in rare circumstances when PC is contraindicated, PC is considered the treatment of choice for patients who are not candidates for cholecystectomy [2,5,6]. PC has been shown to be lifesaving in high-risk patients [7] and should be considered a reasonable option in the therapeutic spectrum for patients with both acalculous and calculous AC as a temporizing measure while awaiting resolution of sepsis and optimization of comorbidities before performing the elective surgery or also as a definite treatment, especially in acalculous forms [7][8][9]. PC seems especially useful for certain categories of patients such as patients in intensive care (where the prevalence of acalculous cholecystitis can be as high as 10 %) and in pregnant women where medical treatment alone for cholecystitis is often not successful [2].…”
Section: Percutaneous Cholecystostomy and Its Role In Management Acutmentioning
confidence: 99%
See 1 more Smart Citation
“…Excluding patients with limited life expectancy caused by advanced malignancy or in rare circumstances when PC is contraindicated, PC is considered the treatment of choice for patients who are not candidates for cholecystectomy [2,5,6]. PC has been shown to be lifesaving in high-risk patients [7] and should be considered a reasonable option in the therapeutic spectrum for patients with both acalculous and calculous AC as a temporizing measure while awaiting resolution of sepsis and optimization of comorbidities before performing the elective surgery or also as a definite treatment, especially in acalculous forms [7][8][9]. PC seems especially useful for certain categories of patients such as patients in intensive care (where the prevalence of acalculous cholecystitis can be as high as 10 %) and in pregnant women where medical treatment alone for cholecystitis is often not successful [2].…”
Section: Percutaneous Cholecystostomy and Its Role In Management Acutmentioning
confidence: 99%
“…The reported success rate of PC is high (approximately 85 %) and the complications are low (about 10 %) [1,2,8].…”
Section: Percutaneous Cholecystostomy and Its Role In Management Acutmentioning
confidence: 99%
“…However, age >70 years is a predictor of failure of conservative treatment [8]. Therefore, PC is a low-risk management option when the patient is too ill to undergo surgery [9].…”
Section: Introductionmentioning
confidence: 99%
“…4,5,10 Image-guided percutaneous cholecystostomy (PC) tube placement has been found to be a safe and effective alternative to cholecystectomy in patients at high risk with serious comorbidities. [11][12][13][14][15][16] This procedure provides an immediate treatment option in these sick patients but is essentially a temporizing measure until the immediate emergency is treated and the patient's medical condition is optimized for an elective cholecystectomy procedure several weeks after placement of the PC tube. 17 Percutaneous cholecystostomy tube placement followed by delayed cholecystectomy has been shown to be an effective treatment option in this high-risk population.…”
mentioning
confidence: 99%